Magnum Ice Cream started trading in Amsterdam on Monday. Shares opened at €12.96, giving the company a market value of €7.93 billion. With this move, the Magnum Ice Cream listing officially completes its spinoff from Unilever.
Unilever chose to separate Magnum because its cold-chain operations are far more complex than those of its other brands. Now that it is independent, Magnum expects a sharper focus on ice cream to boost productivity and innovation.
However, the debut faces early challenges. Shares are not yet eligible for major indices like the FTSE. As a result, Magnum warned that the stock could face downward pressure. In addition, the company confirmed it will not pay a dividend in 2026.
Analysts had expected a higher valuation. Earlier, Barclays forecast a share price above €20 and an equity value between €10.1 billion and €10.8 billion. Yet the final reference price was set at just €12.80.
According to Degroof Petercam, the lower price made the stock more attractive to new investors. It also helped avoid a sharp drop that could come from index fund selling. Moreover, weak demand and high separation costs likely added short-term pressure.
On the same day, Magnum also began trading in London and New York. As the world’s largest standalone ice cream maker, it now owns brands like Wall’s, Cornetto, and Ben & Jerry’s.
Meanwhile, its main rival Froneri was valued at €15 billion in October. Froneri holds an 11% global market share. By comparison, Magnum commands 21% of the $87 billion global ice cream market.
Despite its strong position, challenges remain. The Ben & Jerry’s brand contributes €1.1 billion in annual sales—nearly 14% of Magnum’s total revenue. Under Unilever, that figure was only 1.8%.
Recently, Magnum told the Ben & Jerry’s Foundation to address weaknesses in governance and financial controls. Otherwise, full funding may be reduced. Given the brand’s activist history, this is a sensitive issue.
Furthermore, shifting health trends could affect demand. Sugary treats may lose appeal as GLP-1 weight-loss drugs grow in popularity. At the same time, political messaging around healthy eating—such as “Make America Healthy Again”—could influence consumer choices.
Nevertheless, CEO Peter ter Kulve called the listing a “proud milestone.” He said independence will make Magnum more agile, focused, and ambitious than ever before.
Unilever’s shares dropped about 4% on Monday, marking the biggest decline on the STOXX 600 index. Investors reacted to the loss of Magnum’s earnings. Even so, Unilever still holds a 19.9% stake and plans to fully exit within five years.
In summary, the Magnum Ice Cream listing presents both clear opportunities and notable risks. While it offers a pure-play investment in global dessert demand, long-term success will depend on navigating brand complexities, market dynamics, and evolving consumer preferences.
